USPTO serial 87278582
COOPERFERTILITY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DANG, PETER T
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COOPERFERTILITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory N. Owen
GREGORY N. OWEN OWEN, WICKERSHAM & ERICKSON, P.C.455 MARKET STREET, SUITE 1910SAN FRANCISCO, CA 94105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for clinical or medical laboratory use; reagent kits comprising generic dna circle, dna primers, polymerase and buffers for use in biotechnology fields; diagnostics for scientific research use, namely, stain used for determining the morphology of sperm and other cells found in semen samples from humans and animals; chemicals used in industry and science, namely, growth media for cell cultures and reagents | ACTIVE | — |
| 005 | Astringents for gynecological use; assisted reproduction culture media, namely, fertilization, cleavage, and blastocyst development media, and cryopreservation media; assisted reproduction andrology media, namely, sperm washing media, sperm freezing media, and sperm preparation media; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; media as diagnostic preparations for use in assisted conception, reproductive medicine, embryology and andrology; tissue culture media for use in laboratory procedures and medical technologies for augmentation of tissue for medical purposes; culture media for use in embryo transfer; culture media for use in in-vitro fertilization procedures; pharmaceutical and veterinary preparations, namely, cell growth media and reagents for medicinal purposes to be used in connection with the extraction of immature eggs, growth, purification and freezing of tissue and cells, and artificial insemination and IVF (in vitro fertilization), in the nature of in vitro maturation of egg cells; chemical preparations for diagnostic purposes in the nature of the diagnosis of patient suitability for in vitro maturation of egg cells and for carrying through artificial insemination and IVF (in vitro fertilization); diagnostic reagents for medical and clinical use, namely, stain used for determining the morphology of sperm and other cells found in semen samples from humans and animals | ACTIVE | — |
| 010 | Medical apparatus, namely, vitrification carriers for vitrification of human blastocysts, human reproductive tissue, human sperm, human oocytes and human embryos used for in vitro fertilization and treatment of infertility and other disorders relating to fertility and human reproduction; medical devices, namely, devices used in the cryopreservation of biological specimens; medical equipment, namely, a vitrification kit for embryos, blastocytes, or other biological cells, comprised of vitrification devices and synthetic media, namely, vitrification and warming solutions; medical equipment, namely, a vitrification device for embryos and blastocytes; cryopreservation device for biological cells for use for in vitro fertilization; medical device for use for in vitro fertilization, namely, incubators; catheters; biological cell sampling needle for medical purposes; medical apparatus and instruments used for the vitrification and cryopreservation of biological cells; medical apparatus for vitrification, cryopreservation, and cryostorage of cells, namely, vessels and canes for the collection, vitrification, cryostorage, and warming of cells; medical instruments for use in the manipulation and transfer of cells during assisted reproduction technology medical procedures | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CooperSurgical, Inc.
- Other trademarks owned by CooperSurgical, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named COOPERFERTILITY
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 18, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 29, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 27, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 27, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 27, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 16, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 21, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 21, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 15, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 2, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 21, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 21, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 21, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 13, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 6, 2017 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Jan 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 27, 2016 | NWAP | NEW APPLICATION ENTERED | — |